EP 1853302 A2 20071114 - ANTIANGIOGENIC AGENTS WITH ALDESLEUKIN
Title (en)
ANTIANGIOGENIC AGENTS WITH ALDESLEUKIN
Title (de)
ANTIANGIOGENE WIRKSTOFFE MIT ALDESLEUKIN
Title (fr)
AGENTS ANTI-ANGIOGENIQUES COMPORTANT DE L'ALDESLEUKINE
Publication
Application
Priority
- US 2006005720 W 20060217
- US 65434105 P 20050218
Abstract (en)
[origin: WO2006089150A2] The present invention relates to combination therapies with IL-2 compositions and antiangiogenic agents for the treatment of cancer. Further provided are methods of alleviating toxicities and increasing the efficacy associated with the administration of IL-2 compositions or antiangiogenic compositions.
IPC 8 full level
A61K 31/404 (2006.01); A61K 31/4412 (2006.01); A61K 31/502 (2006.01); A61K 31/517 (2006.01); A61K 38/20 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR)
A61K 31/404 (2013.01 - EP); A61K 31/4412 (2013.01 - EP); A61K 31/502 (2013.01 - EP KR); A61K 31/517 (2013.01 - EP KR); A61K 38/20 (2013.01 - KR); A61K 38/2013 (2013.01 - EP); A61P 9/00 (2017.12 - EP); A61P 9/02 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2006089150A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006089150 A2 20060824; WO 2006089150 A3 20061102; AU 2006214138 A1 20060824; BR PI0608880 A2 20100202; CA 2598448 A1 20060824; CN 101146549 A 20080319; EP 1853302 A2 20071114; JP 2008530239 A 20080807; KR 20070108909 A 20071113; MX 2007010037 A 20080215; RU 2007134570 A 20090327
DOCDB simple family (application)
US 2006005720 W 20060217; AU 2006214138 A 20060217; BR PI0608880 A 20060217; CA 2598448 A 20060217; CN 200680009316 A 20060217; EP 06735400 A 20060217; JP 2007556337 A 20060217; KR 20077021118 A 20070914; MX 2007010037 A 20060217; RU 2007134570 A 20060217